Miniaturisation - Micro Scale Bioprocess Development
"Miniaturisation and automation of bioprocess development holds great promise in reducing the time and cost to market of new biopharmaceuticals. This meeting aims to highlight recent technologies used in high throughput bioprocess development, from clone selection through to analysis of final product and formulation. A series of expert speakers will describe the development and use of current miniaturisation technologies together with the technical and regulatory hurdles that must be overcome to facilitate wider industrial uptake."
The event has CPD approval and a troubleshooting panel session. On registration you will be able to submit your questions to the panel that will be asked by the chair on the day of the event.
For further details contact Astrid Englezou
email address: enquiries@euroscicon.com
| Event start date: | 24 September 2010 |
|---|---|
| Event end date: | 24 September 2010 |
| Location: | The BioPark, Welwyn Garden City, Herts |
| Key Speakers: | Professor Gary Lye, Professor of Biochemical Engineering, University College London Dr Ray Field, Director Cell Sciences, MedImmune, Cambridge, UK. Dr Jonathan Dempsey, Life Technologies, UK Dr Kenneth Lee, The Automation Partnership, UK Dr Jonathan Souquet, Eden Biodesign Ltd., Liverpool, UK Dr Sam Denby, Oxford Biomedica, UK Dr Anna Grönberg, GE Healthcare¸UK |
| External URL: | www.euroscicon.com |
